|
Market Cap (5-Jul) $277,062,656 (480th) |
Close (30-Jun) $3.40 |
Volume (30-Jun) 0 |
Shortsold (6-Aug) 667 (0.00%) (670th) |
|
52w High $3.12 |
52w Low $2.13 |
P/E 22.37 |
EPS 0.1 |
AFP released this announcement to the ASX on 17 March 2021, 9:14. The announcement is not marked as price sensitive, and is 2 page(s) in length and 125.47kb in size.
You can view all announcements from AFP and see how they appear on a price chart on the announcements page.
At the date of this announcement, AFP was 0.001% short sold according to ASIC data. It was ranked the 650th most shorted stock on the ASX. It remains ranked 670th as of the latest reported data (06 August 2021).
| Other Recent Announcements from AFP | |
|---|---|
| Notice of Annual Meeting of Shareholders 2023 | 30 June 2023, 7:30 |
| Dividend/Distribution - AFP | 30 May 2023, 14:13 |
| Annual Meeting and Closing Date for Director Nominations | 26 May 2023, 14:58 |
| AFT licenses Pascomer for Europe | 17 March 2021, 9:14 |
| MAXIGESIC IV LICENSED IN EIGHT NEW EUROPEAN MARKETS | 5 March 2021, 7:31 |
| 24-hour efficacy for Crystawash Extend Hand Sanitiser | 11 January 2021, 9:30 |
| AFP builds North American momentum | 23 December 2020, 7:30 |
You must be logged in to post a reply.
AFT Pharmaceuticals 